Escape to the future: Pharmaceutical ind • Table.Briefings

The EU Commission intends to revise European pharmaceutical legislation at the end of 2022. Even during the consultations at the end of 2021, the pharmaceutical industry did not see any fundamental need for improvement. However, now, it is taking the plunge and presenting its own proposals to make access to medicines faster and fairer for millions of patients in the EU.

The planned measures by the member companies of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which include 20 of the world’s largest pharmaceutical companies, are intended to „significantly increase“ the availability of innovative medicines in EU countries. In addition, patients’ waiting time for new medicines is to be reduced by several months, according to the current EFPIA statement.

Escape to the future: Pharmaceutical industry wants to improve access to medicines

Sign up now and continue reading immediately